Mechanistically, tamoxifen cross-activates GPER, inducing proliferation of resistant breast cancer cells and promoting the nuclear expulsion of the pro-apoptotic transcription factor FOXO3a, thereby shifting cells toward a pro-survival state (314). The gene discussed is FOXO3; the disease is breast carcinoma.